# AgomAB Therapeutics funding: rounds and investors > AgomAB Therapeutics has raised $112M across 2 rounds since 2019. Investors include V-Bio Ventures, Advent France Biotechnology and Canaan. Source: https://millionrounds.com/company/agomab-therapeutics (Millionrounds; every figure on the page links to its filing or article) Belgium · [Series D startup](https://millionrounds.com/companies) # Who invested in *AgomAB Therapeutics* 2 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$112M** raised across 2 rounds since 2019, from 2 sources **$24M** Series A **$89M** Series D - **Latest round:** Series D, $89M Oct 2024 - **Step-up i:** 3.8× - **Investors:** 10 (2 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2019 2020 2021 2022 2023 2024 **$24M** Series A **$89M** Series D - **First round:** Series A, $24M - **Biggest round:** $89M - **Between rounds:** 5.5 years ## The rounds - **Oct 2024** Series D **$89M** *5 new* [Canaan](https://millionrounds.com/fund/canaan-partners) [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [Sanofi](https://millionrounds.com/fund/sanofi) [EQT Life Sciences](https://millionrounds.com/fund/eqt-life-sciences) [Andera Partners](https://millionrounds.com/fund/andera-partners) Source recorded - **Apr 2019** Series A **$24M** *5 new* [V-Bio Ventures](https://millionrounds.com/fund/v-bio-ventures) Lead [Advent France Biotechnology](https://millionrounds.com/fund/advent-france-biotechnology) Lead [Omnes](https://millionrounds.com/fund/omnes-capital) [Boehringer Ingelheim](https://millionrounds.com/fund/boehringer-ingelheim) Pontifax Reported by FinSMEs ## Founders and team From AgomAB Therapeutics's own website: 11 on the team. - **Tim Knotnerus** Chief Executive Officer - **Andrea Sáez** Chief Development Officer - **Paul van der Horst** Chief Business Officer - **Philippe Wiesel** Chief Medical Officer - **Pierre Kemula** Chief Financial Officer - **Angelika Jahreis** Non-Executive Director - **Colin Bond** Non-Executive Director and Chairman of the Audit Committee. - **David Epstein** Chairman of the Board - **Ellen Lefever** General Counsel - **Marino Garcia** Non-Executive Director - **Naimish Patel** Non-Executive Director ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2019 **Series D** 2024 [V-Bio Ventures](https://millionrounds.com/fund/v-bio-ventures) L [Advent France Biotechnology](https://millionrounds.com/fund/advent-france-biotechnology) L [Canaan](https://millionrounds.com/fund/canaan-partners) [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [Omnes](https://millionrounds.com/fund/omnes-capital) [Sanofi](https://millionrounds.com/fund/sanofi) [EQT Life Sciences](https://millionrounds.com/fund/eqt-life-sciences) [Andera Partners](https://millionrounds.com/fund/andera-partners) [Boehringer Ingelheim](https://millionrounds.com/fund/boehringer-ingelheim) Pontifax ## Everyone who backed them [V-Bio Ventures](https://millionrounds.com/fund/v-bio-ventures) VC firm **1** round, led 1 [Advent France Biotechnology](https://millionrounds.com/fund/advent-france-biotechnology) VC firm **1** round, led 1 [Canaan](https://millionrounds.com/fund/canaan-partners) VC firm **1** round [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) Private equity **1** round [Omnes](https://millionrounds.com/fund/omnes-capital) VC firm **1** round [Sanofi](https://millionrounds.com/fund/sanofi) Investment firm **1** round [EQT Life Sciences](https://millionrounds.com/fund/eqt-life-sciences) VC firm **1** round [Andera Partners](https://millionrounds.com/fund/andera-partners) Private equity **1** round [Boehringer Ingelheim](https://millionrounds.com/fund/boehringer-ingelheim) VC firm **1** round Pontifax no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=agomab-therapeutics). ## Also claim to have backed them This firm lists AgomAB Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [AdBio partners](https://millionrounds.com/fund/adbio-partners) VC firm Per its own site ## Quick answers about AgomAB Therapeutics ### Who invested in AgomAB Therapeutics? AgomAB Therapeutics's investors include V-Bio Ventures, Advent France Biotechnology, Canaan, Cormorant Asset Management and Omnes, and 5 more on record. ### How much has AgomAB Therapeutics raised? AgomAB Therapeutics has raised $112M across 2 rounds since 2019. ### When did AgomAB Therapeutics last raise? AgomAB Therapeutics's most recent round was a Series D of $89M in Oct 2024. ### What was AgomAB Therapeutics's biggest round? Its most recent round, $89M in Oct 2024, is also its largest on record. ### Who backed AgomAB Therapeutics first? AgomAB Therapeutics's first round on record, in Apr 2019, was backed by V-Bio Ventures, Advent France Biotechnology and Omnes and 2 others. ### What stage is AgomAB Therapeutics at? AgomAB Therapeutics's latest named round is a Series D, in Oct 2024. ### Where is AgomAB Therapeutics based? AgomAB Therapeutics is based in Belgium. ### Who led AgomAB Therapeutics's rounds? V-Bio Ventures led the Series A in 2019. ## Companies like AgomAB Therapeutics In the same sector, and raised in the last eighteen months. [**Novadip Biosciences** $43M · Sept 2026](https://millionrounds.com/company/novadip-biosciences)[**Amyl Therapeutics** $9.6M · Sept 2026](https://millionrounds.com/company/amyl-therapeutics)[**Revier Therapeutics** $7.0M · Aug 2026](https://millionrounds.com/company/revier-therapeutics)[**Sightera Biosciences** $3.4M · Jul 2026](https://millionrounds.com/company/sightera-biosciences)[**Rainbow Crops** $18M · Jun 2026](https://millionrounds.com/company/rainbow-crops)[**ReVision Implant** $4.7M · May 2026](https://millionrounds.com/company/revision-implant) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app